19. Quality Assessment of Controlled Intervention Studies- NHLBI, NIH [ Internet ]. National Heart, Lung, and Blood Institute. 2016 [ cited 19 October 2016 ]. Available from: http:// www. nhlbi. nih. gov / health-pro / guidelines / in-develop / cardiovascular-risk-reduction / tools / rct
20. Dayan GH, Garbes P, Noriega F, de Sadovsky AD, Rodrigues PM, Giuberti C, et al. Immunogenicity and safety of a recombinant tetravalent dengue vaccine in children and adolescents ages 9 – 16 years in Brazil. The American journal of tropical medicine and hygiene. 2013 Dec; 89( 6): 1058-65.
21. Amar-Singh HS, Koh MT, Tan KK, Chan LG, Zhou L, Bouckenooghe A, et al. Safety and immunogenicity of a tetravalent dengue vaccine in healthy children aged 2 – 11 years in Malaysia: A randomized, placebo-controlled, Phase III study. Vaccine. 2013 Dec; 31( 49): 5814-21.
22. Lanata CF, Andrade T, Gil AI, Terrones C, Valladolid O, Zambrano B, et al. Immunogenicity and safety of tetravalent dengue vaccine in 2 – 11 year-olds previously vaccinated against yellow fever: randomized, controlled, phase II study in Piura, Peru. Vaccine. 2012 Sep; 30( 41): 5935-41.
23. Sabchareon A, Wallace D, Sirivichayakul C, Limkittikul K, Chanthavanich P, Suvannadabba S, et al. Protective efficacy of the recombinant, live-attenuated, CYD tetravalent dengue vaccine in Thai schoolchildren: a randomised, controlled phase 2b trial. The Lancet. 2012 Nov; 380( 9853): 1559-67.
24. Villar LÁ, Rivera-Medina DM, Arredondo-García JL, Boaz M, Starr-Spires L, Thakur M, Zambrano B, et al. Safety and immunogenicity of a recombinant tetravalent dengue vaccine in 9 – 16 year olds: a randomized, controlled, phase II trial in Latin America. The Pediatric infectious disease journal. 2013 Oct; 32( 10): 1102-9.
25. Sin Leo Y, Wilder-Smith A, Archuleta S, Shek LP, Chong CY, Nam Leong H, et al. Immunogenicity and safety of recombinant tetravalent dengue vaccine( CYD-TDV) in individuals aged 2 – 45 years: Phase II randomized controlled trial in Singapore. Human vaccines & immunotherapeutics. 2012 Sep; 8( 9): 1259-71.